Boehringer Japan Logs 14 Consecutive Years of Growth in Ethical Drug Sales

Nippon Boehringer Ingelheim President Yoshiaki Aono Boehringer Ingelheim Japan said on April 17 that it rang up ethical drug sales of 258.6 billion yen on an NHI price basis in 2016, up 1.0% over the previous year, extending a streak...read more